期刊文献+

琥珀酸去甲文拉法辛缓释片的质量检测 被引量:1

Quality control of desvenlafaxine succinate extended-release tablets
下载PDF
导出
摘要 目的建立琥珀酸去甲文拉法辛缓释片释放度、含量、含量均匀度及有关物质检测方法,并进行方法学验证。方法采用紫外分光光度法测定释放度,高效液相色谱法测定含量、含量均匀度及有关物质,分别考察专属性、线性、回收率、精密度及稳定性等,进行方法学验证。结果释放度方法学验证结果显示,该方法专属性好,在10~200μg/ml范围内线性关系良好,回收率、重复性及中间精密度均符合要求;含量、含量均匀度检测方法验证结果显示,该方法专属性良好,在5~400μg/ml范围内线性关系良好,回收率、重复性及中间精密度均符合要求,溶液在24 h内稳定;有关物质方法学验证结果显示,该方法专属性好,灵敏度高,线性、回收率均符合要求,且溶液在室温条件下放置24 h稳定性良好。结论释放度检测方法简单、灵敏、专属性好、准确度高,含量及含量均匀度检测方法准确可靠,有关物质检测方法准属性好、灵敏度高,均可用于琥珀酸去甲文拉法辛缓释片的质量控制。 Objective To establish and validate the assay methods of release,content,content uniformity and related substances of desvenlafaxine succinate(DVS)in extended- release tablets. Methods The ultraviolet spectrophotometric method was used to determine the DVS release from DVS extended-release tablets. The content uniformity,content and related substance were determined by high-performance liquid chromatography(HPLC). To validate all the method,we respectively examined specificity,linearity,recovery rate,precision and stability,etc. Results The results showed that the analysis method for release was specific,the calibration curve was linear in the range of 10-200 μg/ml,and all the recovery,repeatability and intermediate precision met requirements.The method for detection of content and content uniformity was specific and linear in the range of 5-400 μg/ml,the recovery,repeatability and intermediate precision met requirements. The method for related substances was specific and sensitive,the linear and recovery rate met the requirements. All of the solutions were stable during 24 h at room temperature. Conclusion The analysis method for release is simple,sensitive,specific and accurate,the method for content and content uniformity is accurate and reliable,and the method for related substances is specific,sensitive and accurate. These methods are suitable for quality control of DVS extendedrelease tablets.
出处 《国际药学研究杂志》 CAS CSCD 北大核心 2016年第3期543-547,共5页 Journal of International Pharmaceutical Research
基金 国家科技重大专项综合性新药研究开发大平台资助项目(2012ZX09301003-001-009)
关键词 琥珀酸去甲文拉法辛 缓释片 紫外分光光度法 高效液相色谱法 质量控制 desvenlafaxine succinate extended-release tablets UV spectrophotometry HPLC quality control
  • 相关文献

参考文献5

二级参考文献47

  • 1Shams ME,Arneth B,Hiemke C,王小艳.CYP2D6的多态性与文拉法辛的临床效应[J].中国处方药,2006,5(10):26-26. 被引量:12
  • 2I.iebowitz M R,Manley A L,Padmanabhan S K,etal. Efficacy,safety, and tolerability of desvenlafaxine 50 rag/day and 100 mg/day in outpatients with major depressive disorder[J]. Curr Med Res Opin,2008,24(7):1877-1890.
  • 3Boyer P, Montqomery S, I.epola U, et al. Efficacy, safety, and tolerability of fixed-dose desvenlafaxine 50 and 100 mg/day for major depressive disorder in a placebo-controlled trial[J]. Int Clin Psychopharrnacol, 2008,23 ( 5 ) : 243-253.
  • 4Thase ME,KornsteinSG,GermainJ M,etal. An integrated analysis of the efficacy of desvenlafaxine compared with place bo in patients with major depressive disorder[J]. CNS Spectr, 2009,14(3) : 144-154.
  • 5Clayton A H, Kornstein S G, Rosas G, et al. An integrated analysis of the safety and tolerability of desvenlafaxine compared with placebo in the treatment of major depressive disorder[J]. CNS Spectr, 2009,14(4):183-195.
  • 6Kamath J, Handratta V. Desvenlafaxine suceinate for major depressive disorder:a critical review of the evidence[J].Expert Rev Neurother,2008,8(12) : 1787-1797.
  • 7Lohoff F W, Rickels K. Desvenlafaxine succinate for the treatment of major depressive disorder[J].Expert Opin Pharmacother,2008,9(12) :2129 -2136.
  • 8Sproule B A, Hazra M,Pollock B G. Desvenlafaxine succinate for major depressive disorder[J].Drugs Today (Barc) ,2008, 44(7):475 -487.
  • 9Perry R, Cassagnol M. Desvenlafaxine: a new serotonin norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder[J]. Clin Ther, 2009,31 (Pt 1) :1374-1404.
  • 10Deecher D C, Beyer C E, Johnston G, et al. Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake in hibitor[J]. J PharmacolExp Ther,2006,318(2):657-665.

共引文献24

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部